Comparison of in vitro cytotoxicity of N-acetyl and N-propionyl derivatives of phenolic thioether amines in melanoma and neuroblastoma cells and the relationship to tyrosinase and tyrosine hydroxylase enzyme activity

Melanoma Research

Volumn 10, Issue 1, 2000, Pages 9-15

  Gili, A ^a   Thomas, P D ^a   Ota, M ^a   Jimbow, K ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

Chemotherapy; Melanoma; Tyrosinase; Tyrosine hydroxylase

Indexed keywords

MONOPHENOL MONOOXYGENASE; N PROPIONYL 4 S CYSTEAMINYLPHENOL; N [2 [(4 PROPIONYLOXYPHENYL)THIO]ETHYL]PROPIONAMIDE; PHENOL DERIVATIVE; SULFIDE; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ARTICLE; CHEMOTHERAPY; CYTOTOXICITY; DERIVATIZATION; ENZYME ACTIVITY; ENZYME ASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IN VITRO STUDY; MELANOMA CELL; NEUROBLASTOMA CELL; PRIORITY JOURNAL; STEM CELL;

EID: 0034050429     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-200010010-00002     Document Type: Article

References (21)

1. 1. Jimbow K, Fitzpatrick TB, Wick M, Goldsmith LA, eds. Biochemistry and physiology of melanin pigmentation. In: Physiology and Molecular Biology of the Skin. New York: Oxford University Press, 1991: 873-909.
2. 2. Prezioso JA, Epperly MW, Wang N, et al. Effects of tyrosinase activity on the cytotoxicity of 4-S-cysteaminylphenol and N-acetyl-4-S-cysteaminylphenol in melanoma cells. Cancer Lett 1992; 63: 73-79.
3. 3. Alena F, Iwashina T, Gili A, et al. Selective in vivo accumulation of N-acetyl-4-S-cysteaminylphenol in B16F10 murine melanoma and enhancement of its in vitro and in vivo antimelanoma effect by combination of buthionine sulfoximine. Cancer Res 1994; 54: 2661-2666.
4. 4. Ito Y, Jimbow K. Selective cytotoxicity of 4-S-cysteaminylphenol on follicular melanocytes of the black mouse: rational basis for its application to melanoma chemotherapy. Cancer Res 1987; 47: 3278-3284.
5. 5. Cooksey CJ, Garratt PJ, Land EJ, Pavel S, Ramsden CA, Riley PA, Smit NP. Evidence of the indirect formation of the catecholic intermediate substrate responsible for the autoactivation kinetics of tyrosinase. J Biol Chem 1997; 272: 26226-26235.
6. 6. Nasrin S, Ichinose H, Hidaka H, et al. Recombinant human tyrosinase hydroxylase types 1-4 show regulating kinetic properties for the natural (6R)-tetraydrobiopterin cofactor. J Biochem 1994; 116: 393-398.
7. 7. Miura S, Ueda T, Jimbow K, et al. Synthesis of cysteinylphenol, cysteaminylphenol and related compounds and in vivo evaluation of anti-melanoma effect. Arch Dermatol Res 1987; 279: 219-225.
8. 8. Alena F, Jimbow K, Ito S. Melanocytotoxicity and antimelanoma effects of phenolic amine compounds in mice in vivo. Cancer Res 1990; 50: 3743-3747.
9. 14C] phenol as a basis for development of antimelanoma and melanoma-radio-imaging agent. Appl Radiat Isot 1994; 45: 703-705.
10. 10. Jimbow M, Marusyk H, Jimbow K. The in vivo melanocytotoxicity and depigmenting potency of N-2,4-acetoxyphenyl thioethyl acetamide in the skin and hair. Br J Dermatol 1995; 133: 526-536.
11. 11. Tandon M, Thomas PD, Shokravi M, Singh S, Samra S, Chang D, Jimbow K. Synthesis of the melanogenesis-based antimelanoma agent, N-propionyl-4-S-cysteaminylphenol, and screening of depigmenting and anti-tumour effects. Biochem Pharm 1998; 55: 2023-2029.
12. 12. Alley MC, Scudlero DA, Monks A, et al. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res 1988; 48: 589-601.
13. 13. Pomerantz SH. Tyrosine hydroxylation catalyzed by mammalian tyrosinase: an improved method of assay. Biochem Biophys Res Commun 1964; 16: 188-194.
14. 3H]tyrosine by charcoal. Life Sci 1986; 39: 2185 2189.
15. 15. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein using the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
16. 16. Minamitsuji Y, Sugtyama S, Singh S, et al. N-propionyl-4-S-cysteaminylphenol exerts selective melanocytotoxicity through apoptotic process. Sapporo Med J 1998; 67: 23-37.
17. 17. Schallreuter KU, Buttner G, Pittelkow MR, Wood JM, Swanson NN, Korner C. Cytotoxicity of 6-biopterin to human melanocytes. Biochem Biophys Res Commun 1994; 204: 43-48.
18. 18. Riley PA, ed. Hydroxyanisole: Recent Advances in Anti-melanoma Therapy. London: IRL Press, 1984.
19. 19. Jimbow K, Iwashina T, Alena F, et al. Exploitation of pigment biosynthesis pathway as a selective chemotherapeutic approach for malignant melanoma. J Invest Dermatol 1993; 100: 231S-238S.
20. 20. Prezioso JA, Damodaran KM, Wang N, Bloomer WD. Mechanism regulating inhibition of thymidylate synthase and growth by gamma-L-glutaminyI-4-hydroxy-3-iodobenzene, a novel melanin precursor, in melanogenic melanoma cells. Biochem Pharmacol 1993; 45: 473-481.
21. 21. Alena F, Dixon W, Thomas P, et al. Glutathione plays a key role in the depigmenting and melanocytotoxic action of N-acetyl-4-S-cysteaminylphenol in black and yellow hair follicles. J Invest Dermatol 1995; 104: 792-797.